Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
80036901000001111 | Vilanterol trifenatate (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
80037001000001110 | Vilanterol trifenatate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Vilanterol trifenatate | Is a | Vilanterol | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler | Has specific active ingredient | False | Vilanterol trifenatate | Inferred relationship | Existential restriction modifier | |
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) | Has specific active ingredient | False | Vilanterol trifenatate | Inferred relationship | Existential restriction modifier | |
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose | Has specific active ingredient | False | Vilanterol trifenatate | Inferred relationship | Existential restriction modifier | |
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose | Has specific active ingredient | False | Vilanterol trifenatate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets